ArticleJNCI cancer spectrum2024

Patient-reported outcome measure (PROM) programs for monitoring symptoms among patients treated with immunotherapy: a scoping review.

Sylvie D Lambert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.